acids) [25] . However, these approaches involved lengthy procedure. Cost of some of the reagents and products sometime formed may be unstable, gets converted to harmful byproducts, hence require special care. Therefore, it is necessary to use a convenient, inexpensive reagent [26] to yield contamination free stable target products.
BDMS (bromodimethylsulfonium bromide) was discovered by Meerwein [27] and acts as a catalyst as well as effective brominating agent in variety of organic transformations [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] .
Because of the advantages such as its low cost, easy accessibility, minimal side products, short time duration for the activation of desired functional groups, BDMS found wide range of applications in the synthetic chemistry. The combination of BDMS-ZnCl 2 was used to convert ketoximes to amides [38] , condensation reaction of three components to α-amino amidine [39] . BDMS was used efficiently for the synthesis of methyl 2-Deoxy-4, 6-Obenzylidene galactopyranoside [40] , dithioacetal derivatives of sugar [41] . Deepak Yadav et al. reported the in situ generation of DMSO during the formation of unsymmetrical ureas from hydroxamic acids using BDMS [42] . The application of BDMS for the synthesis of N α -protected ureidopeptides is not established according to the literature survey. Hence, herein we report a mild and efficient route for the synthesis of biologically active peptidylureas employing BDMS in one-pot. Further, the synthesized compounds were screened for in-silico molecular docking and in-vivo anti-bacterial studies. replacements to BDMS. But the yields in these cases were only up to 79-82% even with higher equivalents (Table 2 ). The overall course of the BDMS activated reaction starting from the corresponding protected amino acid was complete within 6 h.
Results and discussion

Chemistry
Further, the protocol was extended to the preparation of a series of N α -protected urea-peptide hybrids (Table 3) 
Molecular docking study of urea derivatives
Three target protein from different organisms namely Escherichia coli (1C14) [43] , Staphylococcus aureus (2UVO) [44] and Pseudomonas aeroginosa (2ZCP) [45] were selected to assess the binding efficacy and inhibitory effects of synthesized compounds against them in the in-silico method. The protein structures were downloaded from Protein Data Bank [46] and cleaned by deleting water molecules and any other heterogeneous molecules that come from crystallographic preparations [47] . Energy minimization of the targets was performed with the help of standard dynamics cascade protocol of Discovery Studio 3.5 (DS 3.5) by 20,000 steps of steepest descent minimization protocol and a standard relaxation procedure using restrained Molecular Dynamics [48] . The active sites were identified based on receptor cavity method using DS 3.5 [49] . 2D structure of all the ligands were drawn in Chemdraw ultra 8.0 and were exported as mol file for further processing in DS 3.5 [50] . Using 'Prepare Ligand' tool in the DS, all possible 3D conformers were generated based on the flexibility of bonds in the molecules. The generated conformers were optimized using CHARMm force field and then minimized through 500 steps of steepest descent minimization algorithm with RMS gradient kept at 0.1. Least energy ligand conformation selected from the generated conformation were then grouped into one library file and subjected to docking. Molecular docking provides preliminary information about the binding modes of ligand molecules in and around receptor cavities as well as predicts possible intermolecular non-covalent bonding. Binding modes may then be used to predict the strength of association between the ligands and receptors using certain scoring functions that include number and types of bonds, hysteric clashes and electronic repulsions as parameters.
The flex docking score correlates with the binding affinity of the molecules with the target [51] . Docking results for all the three compounds against three different target proteins were tabulated in Table 4 
Antibacterial activity
The urea derivative showed significant improved antibacterial activity against tested macrolide-susceptible and resistant strain [52] . In the present work, antibacterial activity of Streptomycin sulphate was used as standard antibiotic. After incubation at 37 °C for 24 h, the diameter of inhibition zone was measured (mm). The inhibition zones of P-1 and DP-1 values were determined.
The antibacterial activity results of the compounds P-1 and DP-3 were exhibited significant activity against two gram +ve and gram -ve pathogens. Wells of approximately 6 mm diameter was made on MH agar plates using gel puncture. All the synthesized compounds were dissolved in DMSO (10 mg/1 mL) separately and varied concentrations of compounds were used to assess the activity. To each well a volume of 50 μl of Streptomycin sulphate standard (2 mg/1 mL) and 50 μl, 100 μl, 200 μl of respective compounds were added to individual plates. Each set of plates were prepared in triplicates and the plates were incubated at 37 °C for 24 hours and the inhibition zones obtained were measured. The samples of protected and deprotected ureas were subjected to antibacterial studies using Streptomycin sulphate. It was observed that compound P-1 and DP-1 derivatives were showed the inhibitory activity against all the three pathogens as reported in respectively. This indicates that, the deprotected ureas have showed more activity compared to protected ureas.
Conclusion
We herein report a simple and efficient protocol for the synthesis of biologically active 
Experimental
General
All chemicals were purchased from Sigma-Aldrich and Merck and used without purification.
IR spectra were recorded on Agilent cary-630 Fourier transform infrared spectrometer. (Table 1 and 2).
Spectral data of synthesized compounds
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